Submission to Pfizer Sample Clauses

Submission to Pfizer. Principal Investigator will provide any Publication to Pfizer at least 30 days before it is submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, Principal Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days. a. Předložení společnosti Pfizer. Hlavní zkoušející předloží jakoukoli Publikaci společnosti Pfizer nejméně 30 dní před tím, než bude předložena ke zveřejnění nebo jinak zpřístupněna. Pokud je zapotřebí jakékoli patentové řízení s cílem ochrany práv duševního vlastnictví, Hlavní zkoušející souhlasí s odložením zveřejnění nejvýše o dodatečných 60 dnů.
Sample 1Sample 2Sample 3See All (8)
AutoNDA by SimpleDocs
Submission to Pfizer. UMCU, also on behalf of the Parties and the other Partners, and ARS, as the case may be, will submit the full text of any proposed Publication to Pfizer at least thirty (30) days before it is submitted for Publication and Pfizer will reply within such thirty (30) days. Pfizer will solely have the right to propose amendments to such Publication on reasonable grounds. If Pfizer determines that Pfizer’s Confidential or patenting information is contained in such Publication, UMCU, also on behalf of the Parties and the other Partners, and ARS, as the case may be, will agree to delete that information. Should there be no comment from Pfizer within the above-mentioned period, Pfizer will be deemed to have accepted the Publication. In the event Pfizer is in the process of filing a patent application to protect intellectual property rights, Pfizer will be able to delay the Publication with a maximum of sixty (60) days. In compliance with the ENCePP Code of Conduct, UMCU, also on behalf of the Parties and the other Partners, and ARS remain free and are not obliged to take into consideration Pfizer’s comments before publication. Authorship will comply with the International Journal Committee of Medical Journal Editors (ICMJE) rules.
Sample 1
Submission to Pfizer. Principal Investigator will provide any Publication to
Sample 1

Related to Submission to Pfizer

  • Permission to Use References in this Agreement to permission to use the Route shall, except where the contrary is indicated, be construed to mean permission:-

  • Permission to Leave Work The Employer agrees that stewards shall not be hindered, coerced, restrained or interfered with in any way in the performance of their duties, while investigating disputes and presenting adjustments as provided in this Article. The Union recognizes that each xxxxxxx is employed by the Employer and that they will not leave their work during working hours except to perform their duties under this Agreement. Therefore, no xxxxxxx shall leave their work without permission of their supervisor, which will not be unreasonably withheld.

  • Notification to Union The Hospital will provide the union with a list, monthly of all hirings, lay-offs, recalls and terminations within the bargaining unit where such information is available or becomes readily available through the Hospital's payroll system."

  • Notification to Employees ‌ The Employer will inform new, transferred, promoted, or demoted employees in writing prior to appointment into positions included in the bargaining unit(s) of the Union’s exclusive representation status. Upon appointment to a bargaining unit position, the Employer will furnish the employees with membership materials provided by the Union. The Employer will inform employees in writing if they are subsequently appointed to a position that is not in a bargaining unit.

  • Notification to Employer The Union shall notify the Employer of the names of the Employees, including the department wherein the Employee is employed, who are members of the Board of Directors, the Union Executive and Council Committees.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!